Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 605,446 | 605,303 | 620,103 | 576,056 | 549,386 |
| Cost of Goods | 274,297 | 260,353 | 262,250 | 244,459 | 249,025 |
| Gross Profit | 331,149 | 344,950 | 357,853 | 331,597 | 300,361 |
| Operating Expenses | 215,815 | 205,501 | 193,828 | 198,918 | 185,039 |
| Operating Income | 115,631 | 139,802 | 164,275 | 133,138 | 115,347 |
| Interest Expense | 7,393 | 7,090 | 8,186 | 8,386 | 8,560 |
| Other Income | 268 | 86 | 33 | 40 | 258 |
| Pre-tax Income | 108,506 | 132,798 | 156,122 | 124,792 | 107,045 |
| Income Tax | 17,962 | 23,960 | 30,421 | 22,083 | 21,368 |
| Net Income Continuous | 90,544 | 108,838 | 125,701 | 102,709 | 85,677 |
| Minority Interests | 48 | 1 | -5 | 28 | 39 |
| Net Income | $90,496 | $108,837 | $125,706 | $102,681 | $85,638 |
| EPS Basic Total Ops | 1.06 | 1.26 | 1.46 | 1.19 | 1.00 |
| EPS Basic Continuous Ops | 1.06 | 1.26 | 1.46 | 1.19 | 0.99 |
| EPS Diluted Total Ops | 1.05 | 1.24 | 1.43 | 1.17 | 0.97 |
| EPS Diluted Continuous Ops | 1.04 | 1.24 | 1.43 | 1.17 | 0.98 |
| EBITDA(a) | $138,220 | $162,248 | $185,896 | $154,493 | $135,951 |